Vanguard Fiduciary Trust
SMTI icon

Vanguard Fiduciary Trust’s Sanara MedTech SMTI Stock Holding History

Vanguard Fiduciary Trust’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
26,027
+652
+3% +$13.5K ﹤0.01% 3203
2026
Q1 		$436K Buy
+25,375
New +$522K ﹤0.01% 3252

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Vanguard Fiduciary Trust's SMTI Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Sanara MedTech (SMTI) stake by 2.6% in Q2 2026, buying an estimated $13.5K and bringing the position to 26,027 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #3203.

Vanguard Fiduciary Trust first reported a position in SMTI in Q1 2026 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Vanguard Fiduciary Trust held 26,027 shares of Sanara MedTech worth $614K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 652 Sanara MedTech shares in Q2 2026, an estimated $13.5K.
  • Sanara MedTech made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3203 holding.
  • Vanguard Fiduciary Trust first reported a position in Sanara MedTech in Q1 2026 and has held it in 2 quarters since.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.